etoposide,cladribine,fludarabine,gilteritinib,enasidenib
Bayer,servier,merck,bms,astellas
['gilteritinib', 'enasidenib', 'fludarabine', 'etoposide', 'leusm', 'cladribine']
#ash22 #leusm #bmtsm michaelis intro for schetelig: conventional approach to primary induction failure is reinduce ion chemo (w ~40% cr rate generally). this study assessed outcomes of direct to allohct without reinduction for pif. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)